<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rehab</journal-id><journal-title-group><journal-title xml:lang="ru">Реабилитология</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Medical Rehabilitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-5873</issn><issn pub-type="epub">2949-5881</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2949-5873/rehabil.2026.71</article-id><article-id custom-type="elpub" pub-id-type="custom">rehab-153</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>За гранью выживания: переосмысление подходов к реабилитации пациентов с венозной тромбоэмболией</article-title><trans-title-group xml:lang="en"><trans-title>Beyond survival: rethinking rehabilitation approaches for venous thromboembolism patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3367-9844</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинов</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Блинов Дмитрий Владиславович, д.м.н.</p><p>Алтуфьевское ш., д. 37А, стр. 1, Москва 127410</p><p>WoS ResearcherID: E-8906-2017. Scopus Author ID: 6701744871</p><p>Лялин пер., д. 11-13/1, Москва 101000</p><p>ул. 2-я Брестская, д. 5, стр. 1-1а, Москва 123056</p></bio><bio xml:lang="en"><p>Dmitry V. Blinov, Dr. Sci. Med., MBA</p><p>WoS ResearcherID: E-8906-2017. Scopus Author ID: 6701744871</p><p>37А bldg 1 Altufyevskoe Shosse, Moscow 127410</p><p>11-13/1 Lyalin Passage, Moscow 101000</p><p>5 bldg 1-1a 2nd Brestskaya Str., Moscow 123056</p></bio><email xlink:type="simple">blinov2010@googlemail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7456-2386</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солопова</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Solopova</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Солопова Антонина Григорьевна, д.м.н., проф.</p><p>ул. Трубецкая, д. 8, стр. 2, Москва 119048</p><p>WoS ResearcherID: Q-1385-2015. Scopus Author ID: 6505479504</p></bio><bio xml:lang="en"><p>Antonina G. Solopova, Dr. Sci. Med., Prof.</p><p>WoS ResearcherID: Q-1385-2015. Scopus Author ID: 6505479504</p><p>8 bldg 2 Trubetskaya Str., Moscow 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7415-4633</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макацария</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Makatsariya</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макацария Александр Давидович, д.м.н., проф., акад. РАН</p><p>ул. Трубецкая, д. 8, стр. 2, Москва 119048</p><p>WoS ResearcherID: M-5660-2016. Scopus Author ID: 57222220144</p></bio><bio xml:lang="en"><p>Alexander D. Makatsariya, Dr. Sci. Med., Prof., RAS Member</p><p>WoS ResearcherID: M-5660-2016. Scopus Author ID: 57222220144</p><p>8 bldg 2 Trubetskaya Str., Moscow 119048</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Федеральный научно-клинический центр медицинской реабилитации и курортологии Федерального медико-биологического агентства»; Институт Превентивной и Социальной Медицины; Автономная некоммерческая организация дополнительного профессионального образования «Московский  медико-социальный институт им. Ф.П. Гааза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency; Institute for Preventive and Social Medicine;  Moscow Haass Medical Social Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации &#13;
(Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>06</day><month>07</month><year>2026</year></pub-date><volume>4</volume><issue>1</issue><fpage>42</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Блинов Д.В., Солопова А.Г., Макацария А.Д., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Блинов Д.В., Солопова А.Г., Макацария А.Д.</copyright-holder><copyright-holder xml:lang="en">Blinov D.V., Solopova A.G., Makatsariya A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rehabilitology.com/jour/article/view/153">https://www.rehabilitology.com/jour/article/view/153</self-uri><abstract><p>Венозная тромбоэмболия (ВТЭ) является значимой причиной смертности и инвалидизации во всем мире. Снижение летальности в острой фазе заболевания привело к росту популяции пациентов, сталкивающихся с долгосрочными последствиями, такими как посттромботический синдром (ПТС) и хроническая тромбоэмболическая легочная гипертензия (ХТЭЛГ), что существенно снижает качество их жизни и накладывает колоссальное экономическое бремя. В статье обоснована необходимость смены парадигмы ведения пациентов с ВТЭ: от лечения острого состояния к модели управления хроническим заболеванием с непрерывным реабилитационным процессом. Подробно рассмотрены фазы заболевания (острая, подострая, хроническая), определяющие характер реабилитационных вмешательств. Пред ставлена этапность медицинской реабилитации, а также описаны структура и функции мультидисциплинарной реабилитационной команды. Особое внимание уделено персонализированным подходам к реабилитации в различных клинических ситуациях: после тромбоэмболии легочной артерии, при тяжелом ПТС и трофических язвах, ХТЭЛГ, у онкологических пациентов, беременных, пожилых, спортсменов и лиц с имплантированным кава-фильтром. Перспективным потенциалом обладают клеточные технологии, внедрение искусственного интеллекта для прогнозирования рисков и телемедицины для повышения приверженности к лечению. Организационными барьерами являются недостаточная доступность и отсутствие стандартизированных протоколов реабилитации. Интеграция реабилитации как  обязательного компонента на всех этапах ведения пациента с ВТЭ – ключевое условие для предотвращения инвалидизирующих осложнений, восстановления функционального статуса, психосоциальной адаптации и улучшения качества жизни данной категории больных.</p></abstract><trans-abstract xml:lang="en"><p>Venous thromboembolism (VTE) remains a leading cause of mortality and disability worldwide. Due to the decline in mortality during the acute phase of the disease, an increasing number of patients experience long-term complications such as postthrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (CTEPH). These complications significantly reduce patients' quality of life while imposing a substantial economic burden. This article therefore argues for a paradigm shift in VTE patient management, from treating the acute condition to managing the chronic disease with a continuous rehabilitation process. The phases of the disease (acute, subacute, and chronic), which determine the nature of rehabilitation interventions, are thoroughly discussed. The stages of medical rehabilitation are outlined, along with the structure and functions of a multidisciplinary rehabilitation team. Particular attention is paid to personalized rehabilitation approaches in various clinical scenarios, such as following a pulmonary embolism, severe PTS with trophic ulcers, CTEPH, as well as in oncology patients, pregnant women, the elderly, athletes and individuals with an implanted vena cava filter. Emerging prospects include cellular technologies, artificial intelligence for risk prediction and telemedicine to improve treatment adherence. However, key organizational barriers remain, primarily limited access to rehabilitation services and a lack of standardized protocols. Hence, integrating rehabilitation as an essential component throughout all stages of VTE patient management not only prevents disabling complications, but also restores functional status, ensuring psychosocial adaptation and improving quality of life for these patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>венозная тромбоэмболия</kwd><kwd>тромбоз глубоких вен</kwd><kwd>тромбоэмболия легочной артерии</kwd><kwd>посттромботический синдром</kwd><kwd>хроническая тромбоэмболическая легочная гипертензия</kwd><kwd>реабилитация</kwd><kwd>качество жизни</kwd></kwd-group><kwd-group xml:lang="en"><kwd>venous thromboembolism</kwd><kwd>deep vein thrombosis</kwd><kwd>pulmonary embolism</kwd><kwd>post-thrombotic syndrome</kwd><kwd>chronic thromboembolic pulmonary hypertension</kwd><kwd>rehabilitation</kwd><kwd>quality of life</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Khan F., Tritschler T., Kahn S.R., Rodger M.A. Venous thromboembolism. Lancet. 2021; 398 (10294): 64–77. https://doi.org/10.1016/S0140-6736(20)32658-1.</mixed-citation><mixed-citation xml:lang="en">Khan F., Tritschler T., Kahn S.R., Rodger M.A. Venous thromboembolism. Lancet. 2021; 398 (10294): 64–77. https://doi.org/10.1016/S0140-6736(20)32658-1.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marschang P., Gerotziafas G., Kozak M., et al. Epidemiology of venous thromboembolism: implications for clinical practice. Pol Arch Intern Med. 2025; 135 (10): 17105. https://doi.org/10.20452/pamw.17105.</mixed-citation><mixed-citation xml:lang="en">Marschang P., Gerotziafas G., Kozak M., et al. Epidemiology of venous thromboembolism: implications for clinical practice. Pol Arch Intern Med. 2025; 135 (10): 17105. https://doi.org/10.20452/pamw.17105.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Huang S.L., Xin H.Y., Wang X.Y., et al. Recent advances on the molecular mechanism and clinical trials of venous thromboembolism. J Inflamm Res. 2023; 16: 6167–78. https://doi.org/10.2147/JIR.S439205.</mixed-citation><mixed-citation xml:lang="en">Huang S.L., Xin H.Y., Wang X.Y., et al. Recent advances on the molecular mechanism and clinical trials of venous thromboembolism. J Inflamm Res. 2023; 16: 6167–78. https://doi.org/10.2147/JIR.S439205.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Radhakrishnan N. Anticoagulation in the prevention and treatment of venous thromboembolism. In: Radhakrishnan N. Genesis, pathophysiology and management of venous and lymphatic disorders. Academic Press; 2022: 317–71. https://doi.org/10.1016/B978-0-32388433-4.00021-8.</mixed-citation><mixed-citation xml:lang="en">Radhakrishnan N. Anticoagulation in the prevention and treatment of venous thromboembolism. In: Radhakrishnan N. Genesis, pathophysiology and management of venous and lymphatic disorders. Academic Press; 2022: 317–71. https://doi.org/10.1016/B978-0-32388433-4.00021-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rathbun S. Thе Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation. 2009; 119 (15): e480–2. https://doi.org/10.1161/CIRCULATIONAHA.108.841403.</mixed-citation><mixed-citation xml:lang="en">Rathbun S. Thе Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation. 2009; 119 (15): e480–2. https://doi.org/10.1161/CIRCULATIONAHA.108.841403.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Survey: Blood clot management is inconsistent – even for patients with the same risk profile. Available at: https://www.dicardiology.com/content/survey-blood-clot-management-inconsistent-evenpatients-same-risk-profile (accessed 07.09.2025).</mixed-citation><mixed-citation xml:lang="en">Survey: Blood clot management is inconsistent – even for patients with the same risk profile. Available at: https://www.dicardiology.com/content/survey-blood-clot-management-inconsistent-evenpatients-same-risk-profile (accessed 07.09.2025).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">The Cost of Venous Thromboembolism. Vascular Disease Management. Available at: https://www.hmpgloballearningnetwork.com/site/vdm/original-contribution/cost-venous-thromboembolism (accessed 07.09.2025).</mixed-citation><mixed-citation xml:lang="en">The Cost of Venous Thromboembolism. Vascular Disease Management. Available at: https://www.hmpgloballearningnetwork.com/site/vdm/original-contribution/cost-venous-thromboembolism (accessed 07.09.2025).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation. 2014; 129 (3): e28–292. https://doi.org/10.1161/01. cir.0000441139.02102.80.</mixed-citation><mixed-citation xml:lang="en">Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation. 2014; 129 (3): e28–292. https://doi.org/10.1161/01. cir.0000441139.02102.80.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grosse S.D., Nelson R.E., Nyarko K.A., et al. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016; 137: 3–10. https://doi.org/10.1016/j.thromres.2015.11.033.</mixed-citation><mixed-citation xml:lang="en">Grosse S.D., Nelson R.E., Nyarko K.A., et al. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016; 137: 3–10. https://doi.org/10.1016/j.thromres.2015.11.033.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mahan C.E., Borrego M.E., Woersching A.L., et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012; 108 (2): 291–302. https://doi.org/10.1160/TH12-03-0162.</mixed-citation><mixed-citation xml:lang="en">Mahan C.E., Borrego M.E., Woersching A.L., et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012; 108 (2): 291–302. https://doi.org/10.1160/TH12-03-0162.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ruppert A., Steinle T., Lees M. Economic burden of venous thromboembolism: a systematic review. J Med Econ. 2011; 14 (1): 65–74. https://doi.org/10.3111/13696998.2010.546465.</mixed-citation><mixed-citation xml:lang="en">Ruppert A., Steinle T., Lees M. Economic burden of venous thromboembolism: a systematic review. J Med Econ. 2011; 14 (1): 65–74. https://doi.org/10.3111/13696998.2010.546465.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Seemann K., Silas U., Bosworth Smith A., et al. The burden of venous thromboembolism in ten countries: a cost-of-illness Markov model on surgical and ICU patients. J Med Econ. 2025; 28 (1): 1–12. https://doi.org/10.1080/13696998.2024.2436797.</mixed-citation><mixed-citation xml:lang="en">Seemann K., Silas U., Bosworth Smith A., et al. The burden of venous thromboembolism in ten countries: a cost-of-illness Markov model on surgical and ICU patients. J Med Econ. 2025; 28 (1): 1–12. https://doi.org/10.1080/13696998.2024.2436797.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Guanella R., Ducruet T., Johri M., et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost. 2011; 9 (12): 2397–405. https://doi.org/10.1111/j.1538-7836.2011.04516.x.</mixed-citation><mixed-citation xml:lang="en">Guanella R., Ducruet T., Johri M., et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost. 2011; 9 (12): 2397–405. https://doi.org/10.1111/j.1538-7836.2011.04516.x.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gee E., Speed V., Alexander P., et al. Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic. Thromb Res. 2025; 252: 109360. https://doi.org/10.1016/j.thromres.2025.109360.</mixed-citation><mixed-citation xml:lang="en">Gee E., Speed V., Alexander P., et al. Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic. Thromb Res. 2025; 252: 109360. https://doi.org/10.1016/j.thromres.2025.109360.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hunter R., Lewis S., Noble S., et al. “Post-thrombotic panic syndrome”: a thematic analysis of the experience of venous thromboembolism. Br J Health Psychol. 2017; 22 (1): 8–25. https://doi.org/10.1111/bjhp.12213.</mixed-citation><mixed-citation xml:lang="en">Hunter R., Lewis S., Noble S., et al. “Post-thrombotic panic syndrome”: a thematic analysis of the experience of venous thromboembolism. Br J Health Psychol. 2017; 22 (1): 8–25. https://doi.org/10.1111/bjhp.12213.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Feehan M., Walsh M., Van Duker H., et al. Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: a cross-sectional structural equation model. Thromb Res. 2018; 172: 181–7. https://doi.org/10.1016/j.thromres.2018.05.025.</mixed-citation><mixed-citation xml:lang="en">Feehan M., Walsh M., Van Duker H., et al. Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: a cross-sectional structural equation model. Thromb Res. 2018; 172: 181–7. https://doi.org/10.1016/j.thromres.2018.05.025.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Небылицин Ю.С. Острый тромбоз глубоких вен нижних конечностей: современное состояние проблемы. Новости хирургии. 2006; 14 (4): 107–16.</mixed-citation><mixed-citation xml:lang="en">Nebylitsin Yu.S. Acute deep vein thrombosis of the lower extremities: the current state of the problem. Novosti Khirurgii. 2006; 14 (4): 107–16 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Nijkeuter M., Hovens M.M.C., Davidson B.L., Huisman M.V. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest. 2006; 129 (1): 192–7. https://doi.org/10.1378/chest.129.1.192.</mixed-citation><mixed-citation xml:lang="en">Nijkeuter M., Hovens M.M.C., Davidson B.L., Huisman M.V. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest. 2006; 129 (1): 192–7. https://doi.org/10.1378/chest.129.1.192.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Neder J.A. Residual exertional dyspnea in cardiopulmonary disease. Ann Am Thorac Soc. 2020; 17 (12): 1516–25. https://doi.org/10.1513/AnnalsATS.202004-398FR.</mixed-citation><mixed-citation xml:lang="en">Neder J.A. Residual exertional dyspnea in cardiopulmonary disease. Ann Am Thorac Soc. 2020; 17 (12): 1516–25. https://doi.org/10.1513/AnnalsATS.202004-398FR.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Højen A.A., Nielsen P.B., Overvad T.F., et al. Long-term management of pulmonary embolism: a review of consequences, treatment, and rehabilitation. J Clin Med. 2022; 11 (19): 5970. https://doi.org/10.3390/jcm11195970.</mixed-citation><mixed-citation xml:lang="en">Højen A.A., Nielsen P.B., Overvad T.F., et al. Long-term management of pulmonary embolism: a review of consequences, treatment, and rehabilitation. J Clin Med. 2022; 11 (19): 5970. https://doi.org/10.3390/jcm11195970.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Salwa K., Kaziród-Wolski K., Rębak D., Sielski J. The role of early rehabilitation in treatment of acute pulmonary embolism – a narrative review. J Clin Med. 2025; 14 (17): 6230. https://doi.org/10.3390/jcm14176230.</mixed-citation><mixed-citation xml:lang="en">Salwa K., Kaziród-Wolski K., Rębak D., Sielski J. The role of early rehabilitation in treatment of acute pulmonary embolism – a narrative review. J Clin Med. 2025; 14 (17): 6230. https://doi.org/10.3390/jcm14176230.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yu A., Ding W., Lin W. et al. Application of pulmonary rehabilitation in patients with pulmonary embolism (review). Exp Ther Med. 2021; 23 (1): 96. https://doi.org/10.3892/etm.2021.11019.</mixed-citation><mixed-citation xml:lang="en">Yu A., Ding W., Lin W. et al. Application of pulmonary rehabilitation in patients with pulmonary embolism (review). Exp Ther Med. 2021; 23 (1): 96. https://doi.org/10.3892/etm.2021.11019.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kenny C., Lennon O., Klok F.A., et al. Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis. Thromb Res. 2025; 246: 109242. https://doi.org/10.1016/j.thromres.2024.109242.</mixed-citation><mixed-citation xml:lang="en">Kenny C., Lennon O., Klok F.A., et al. Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis. Thromb Res. 2025; 246: 109242. https://doi.org/10.1016/j.thromres.2024.109242.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Klok F.A., Van Kralingen K.W., Van Dijk A.P.J., et al. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010; 95 (6): 970–5. https://doi.org/10.3324/haematol.2009.018960.</mixed-citation><mixed-citation xml:lang="en">Klok F.A., Van Kralingen K.W., Van Dijk A.P.J., et al. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010; 95 (6): 970–5.  https://doi.org/10.3324/haematol.2009.018960.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tapson V.F., Platt D.M., Xia F., et al. Monitoring for pulmonary hypertension following pulmonary embolism: the INFORM study. Am J Med. 2016; 129 (9): 978–85.e2. https://doi.org/10.1016/j.amjmed.2016.03.006.</mixed-citation><mixed-citation xml:lang="en">Tapson V.F., Platt D.M., Xia F., et al. Monitoring for pulmonary hypertension following pulmonary embolism: the INFORM study. Am J Med. 2016; 129 (9): 978–85.e2. https://doi.org/10.1016/j.amjmed.2016.03.006.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Barco S., Mavromanoli A.C., Kreitner K.F., et al. Preexisting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism. Chest. 2023; 163 (4): 923–32. https://doi.org/10.1016/j.chest.2022.11.045.</mixed-citation><mixed-citation xml:lang="en">Barco S., Mavromanoli A.C., Kreitner K.F., et al. Preexisting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism. Chest. 2023; 163 (4): 923–32. https://doi.org/10.1016/j.chest.2022.11.045.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Teerapuncharoen K., Bag R. Chronic thromboembolic pulmonary hypertension. Lung. 2022: 200 (7): 1–17. https://doi.org/10.1007/s00408-022-00539-w.</mixed-citation><mixed-citation xml:lang="en">Teerapuncharoen K., Bag R. Chronic thromboembolic pulmonary hypertension. Lung. 2022: 200 (7): 1–17. https://doi.org/10.1007/s00408-022-00539-w.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Delcroix M., Torbicki A., Gopalan D., et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021; 57 (6): 2002828. https://doi.org/10.1183/13993003.02828-2020.</mixed-citation><mixed-citation xml:lang="en">Delcroix M., Torbicki A., Gopalan D., et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021; 57 (6): 2002828. https://doi.org/10.1183/13993003.02828-2020.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Barret T., Degano B., Bouvaist H., et al. Routine rehabilitation as a treatment component for patients with pulmonary arterial or chronic thromboembolic pulmonary hypertensions. J Cardiopulm Rehabil Prev. 2023; 43 (5): 354–60. https://doi.org/10.1097/HCR.0000000000000755.</mixed-citation><mixed-citation xml:lang="en">Barret T., Degano B., Bouvaist H., et al. Routine rehabilitation as a treatment component for patients with pulmonary arterial or chronic thromboembolic pulmonary hypertensions. J Cardiopulm Rehabil Prev. 2023; 43 (5): 354–60. https://doi.org/10.1097/HCR.0000000000000755.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Visconti L., Celi A., Carrozzi L., et al. Inferior vena cava filters: concept review and summary of current guidelines. Vasc Pharmacol. 2024; 155: 107375. https://doi.org/10.1016/j.vph.2024.107375.</mixed-citation><mixed-citation xml:lang="en">Visconti L., Celi A., Carrozzi L., et al. Inferior vena cava filters: concept review and summary of current guidelines. Vasc Pharmacol. 2024; 155: 107375. https://doi.org/10.1016/j.vph.2024.107375.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Benedetti R., Marino S., Tangianu F., Imberti D. Inferior vena cava filters: a clinical review and future perspectives. J Clin Med. 2024; 13 (6): 1761. https://doi.org/10.3390/jcm13061761.</mixed-citation><mixed-citation xml:lang="en">Benedetti R., Marino S., Tangianu F., Imberti D. Inferior vena cava filters: a clinical review and future perspectives. J Clin Med. 2024; 13 (6): 1761. https://doi.org/10.3390/jcm13061761.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Rezaei-Kalantari K., Rotzinger D.C., Qanadli S.D. Vena cava filters: toward optimal strategies for filter retrieval and patients’ follow-up. Front Cardiovasc Med. 2022; 9: 746748. https://doi.org/10.3389/fcvm.2022.746748.</mixed-citation><mixed-citation xml:lang="en">Rezaei-Kalantari K., Rotzinger D.C., Qanadli S.D. Vena cava filters: toward optimal strategies for filter retrieval and patients’ follow-up. Front Cardiovasc Med. 2022; 9: 746748. https://doi.org/10.3389/fcvm.2022.746748.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Falanga A., Ay C., Di Nisio M., et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023; 34 (5): 452–67. https://doi.org/10.1016/j.annonc.2022.12.014.</mixed-citation><mixed-citation xml:lang="en">Falanga A., Ay C., Di Nisio M., et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023; 34 (5): 452–67. https://doi.org/10.1016/j.annonc.2022.12.014.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Sørensen H.T., Pedersen L., Van Es N., et al. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study. Lancet Reg Health Eur. 2023; 34: 100739. https://doi.org/10.1016/j.lanepe.2023.100739.</mixed-citation><mixed-citation xml:lang="en">Sørensen H.T., Pedersen L., Van Es N., et al. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study. Lancet Reg Health Eur. 2023; 34: 100739. https://doi.org/10.1016/j.lanepe.2023.100739.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Canonico M.E., Santoro C., Avvedimento M., et al. Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment. Biomolecules. 2022; 12 (2): 259. https://doi.org/10.3390/biom12020259.</mixed-citation><mixed-citation xml:lang="en">Canonico M.E., Santoro C., Avvedimento M., et al. Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment. Biomolecules. 2022; 12 (2): 259. https://doi.org/10.3390/biom12020259.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Khorana A.A., Mackman N., Falanga A., et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022; 8 (1): 11. https://doi.org/10.1038/s41572-022-00336-y.</mixed-citation><mixed-citation xml:lang="en">Khorana A.A., Mackman N., Falanga A., et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022; 8 (1): 11.  https://doi.org/10.1038/s41572-022-00336-y.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Grifoni E., Baroncelli A., Pinto G., et al. Efficacy and safety of edoxaban in cancer-associated venous thromboembolism: a real world retrospective study. TH Open. 2022; 6 (2): e99–106. https://doi.org/10.1055/a-1783-9744.</mixed-citation><mixed-citation xml:lang="en">Grifoni E., Baroncelli A., Pinto G., et al. Efficacy and safety of edoxaban in cancer-associated venous thromboembolism: a real world retrospective study. TH Open. 2022; 6 (2): e99–106. https://doi.org/10.1055/a-1783-9744.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wu S., Guan C., Chang S., et al. Comparison of the efficacy and safety of rivaroxaban and low molecular heparin in preventing venous thromboembolism in inpatient cancer patients. Ann Pharmacother. 2024; 58 (3): 214–22. https://doi.org/10.1177/10600280231178335.</mixed-citation><mixed-citation xml:lang="en">Wu S., Guan C., Chang S., et al. Comparison of the efficacy and safety of rivaroxaban and low molecular heparin in preventing venous thromboembolism in inpatient cancer patients. Ann Pharmacother. 2024; 58 (3): 214–22. https://doi.org/10.1177/10600280231178335.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Coleman C.I., Caroti K.S., Abdelgawwad K., et al. Effectiveness and safety of rivaroxaban and low molecular weight heparin in cancerassociated venous thromboembolism. JACC CardioOncol. 2023; 5 (2): 189–200. https://doi.org/10.1016/j.jaccao.2022.10.014.</mixed-citation><mixed-citation xml:lang="en">Coleman C.I., Caroti K.S., Abdelgawwad K., et al. Effectiveness and safety of rivaroxaban and low molecular weight heparin in cancerassociated venous thromboembolism. JACC CardioOncol. 2023; 5 (2): 189–200. https://doi.org/10.1016/j.jaccao.2022.10.014.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Li X.B., Peng K.W., Ji Z.H., et al. Prevention of venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: development of a physiotherapy program. Clin Appl Thromb Hemost. 2019; 25: 1076029619890415. https://doi.org/10.1177/1076029619890415.</mixed-citation><mixed-citation xml:lang="en">Li X.B., Peng K.W., Ji Z.H., et al. Prevention of venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: development of a physiotherapy program. Clin Appl Thromb Hemost. 2019; 25: 1076029619890415. https://doi.org/10.1177/1076029619890415.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bitsadze V., Khizroeva J., Alexander M., Elalamy I. Venous thrombosis risk factors in pregnant women. J Perinat Med. 2022; 50 (5): 505–18. https://doi.org/10.1515/jpm-2022-0008.</mixed-citation><mixed-citation xml:lang="en">Bitsadze V., Khizroeva J., Alexander M., Elalamy I. Venous thrombosis risk factors in pregnant women. J Perinat Med. 2022; 50 (5): 505–18. https://doi.org/10.1515/jpm-2022-0008.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Kalaitzopoulos D.R., Panagopoulos A., Samant S., et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022; 211: 106–13. https://doi.org/10.1016/j.thromres.2022.02.002.</mixed-citation><mixed-citation xml:lang="en">Kalaitzopoulos D.R., Panagopoulos A., Samant S., et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022; 211: 106–13. https://doi.org/10.1016/j.thromres.2022.02.002.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Bukhari S., Fatima S., Barakat A.F., et al. Venous thromboembolism during pregnancy and postpartum period. Eur J Intern Med. 2022; 97: 8–17. https://doi.org/10.1016/j.ejim.2021.12.013.</mixed-citation><mixed-citation xml:lang="en">Bukhari S., Fatima S., Barakat A.F., et al. Venous thromboembolism during pregnancy and postpartum period. Eur J Intern Med. 2022; 97: 8–17. https://doi.org/10.1016/j.ejim.2021.12.013.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Raia-Barjat T., Edebiri O., Chauleur C. Venous thromboembolism risk score and pregnancy. Front Cardiovasc Med. 2022; 9: 863612. https://doi.org/10.3389/fcvm.2022.863612.</mixed-citation><mixed-citation xml:lang="en">Raia-Barjat T., Edebiri O., Chauleur C. Venous thromboembolism risk score and pregnancy. Front Cardiovasc Med. 2022; 9: 863612.  https://doi.org/10.3389/fcvm.2022.863612.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Zachariah K.A., Yuan S., DeSancho M.T., et al. Role of antiplatelets and anticoagulation therapies in pregnancy. J Clin Med. 2024; 13 (24): 7757. https://doi.org/10.3390/jcm13247757.</mixed-citation><mixed-citation xml:lang="en">Zachariah K.A., Yuan S., DeSancho M.T., et al. Role of antiplatelets and anticoagulation therapies in pregnancy. J Clin Med. 2024; 13 (24): 7757. https://doi.org/10.3390/jcm13247757.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Novak P., Novak A., Šabović M., Kozak M. Prophylactic dose of dalteparin in pregnant women with history of venous thromboembolisms and/or thrombophilia: real-world data. Angiology. 2023; 74 (8): 783–9. https://doi.org/10.1177/00033197221126244.</mixed-citation><mixed-citation xml:lang="en">Novak P., Novak A., Šabović M., Kozak M. Prophylactic dose of dalteparin in pregnant women with history of venous thromboembolisms and/or thrombophilia: real-world data. Angiology. 2023; 74 (8): 783–9. https://doi.org/10.1177/00033197221126244.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Purwandityo A.G., Finnegan M.S., Putri M.D., et al. Anticoagulant use to treat VTE (venous thromboembolism) in pregnancy: a review. Indones J Pharmacol Ther. 2022; 3 (3): 3238. https://doi.org/10.22146/ijpther.3238.</mixed-citation><mixed-citation xml:lang="en">Purwandityo A.G., Finnegan M.S., Putri M.D., et al. Anticoagulant use to treat VTE (venous thromboembolism) in pregnancy: a review. Indones J Pharmacol Ther. 2022; 3 (3): 3238. https://doi.org/10.22146/ijpther.3238.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Mori K., Koshiyama M., Watanabe Y., et al. The effect of wearing elastic compression stockings on leg edema in pregnant women in late pregnancy as determined by measuring the deep venous velocity and flow. Healthcare. 2025; 13 (3): 214. https://doi.org/10.3390/healthcare13030214.</mixed-citation><mixed-citation xml:lang="en">Mori K., Koshiyama M., Watanabe Y., et al. The effect of wearing elastic compression stockings on leg edema in pregnant women in late pregnancy as determined by measuring the deep venous velocity and flow. Healthcare. 2025; 13 (3): 214. https://doi.org/10.3390/healthcare13030214.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado García D.R., Real Valdés R., Serrano Rodríguez M.L., et al. Massive deep vein thrombosis in pregnant women: the importance of individualizing the action plan. Rev Esp Anestesiol Reanim. 2022; 69 (8): 497–501. https://doi.org/10.1016/j.redare.2021.07.005.</mixed-citation><mixed-citation xml:lang="en">Delgado García D.R., Real Valdés R., Serrano Rodríguez M.L., et al. Massive deep vein thrombosis in pregnant women: the importance of individualizing the action plan. Rev Esp Anestesiol Reanim. 2022; 69 (8): 497–501. https://doi.org/10.1016/j.redare.2021.07.005.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Завьялов А.А., Грибкова И.В. Особенности пожилых пациентов: как их учитывать при назначении антикоагулянтной терапии? Клинический вестник ФМБЦ им. А.И. Бурназяна. 2023; 3: 35–40. https://doi.org/10.33266/2782-6430-2023-3-35-40.</mixed-citation><mixed-citation xml:lang="en">Zavialov A.A., Gribkova I.V. Features of elderly patients: how to take them into account when prescribing anticoagulant therapy? A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2023; 3: 35–40 (in Russ.). https://doi.org/10.33266/2782-6430-2023-3-35-40.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Mismetti P., Bertoletti L., Gouin I., et al. Elderly patients with venous thromboembolism: Insights from the RIETE registry. Presse Med. 2024; 53 (4): 104246. https://doi.org/10.1016/j.lpm.2024.104246.</mixed-citation><mixed-citation xml:lang="en">Mismetti P., Bertoletti L., Gouin I., et al. Elderly patients with venous thromboembolism: Insights from the RIETE registry. Presse Med. 2024; 53 (4): 104246. https://doi.org/10.1016/j.lpm.2024.104246.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Bura-Riviere A., Verset L., Lapebie F. Venous thromboembolism in the elderly. In: Sinclair A.J., Morley J.E., Vellas B., et al. (Eds) Pathy’s principles and practice of geriatric medicine. Wiley-Blackwell; 2022: 493–8.</mixed-citation><mixed-citation xml:lang="en">Bura-Riviere A., Verset L., Lapebie F. Venous thromboembolism in the elderly. In: Sinclair A.J., Morley J.E., Vellas B., et al. (Eds) Pathy’s principles and practice of geriatric medicine. Wiley-Blackwell; 2022: 493–8.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou X., Yang Y., Zhai Z., et al. Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism: a multicenter study report. BMC Pulm Med. 2024; 24 (1): 26. https://doi.org/10.1186/s12890-023-02824-7.</mixed-citation><mixed-citation xml:lang="en">Zhou X., Yang Y., Zhai Z., et al. Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism: a multicenter study report. BMC Pulm Med. 2024; 24 (1): 26. https://doi.org/10.1186/s12890-023-02824-7.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Minardi S., Sciarra L., Robles A.G., et al. Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation. Front Pharmacol. 2024; 15: 1384213. https://doi.org/10.3389/fphar.2024.1384213.</mixed-citation><mixed-citation xml:lang="en">Minardi S., Sciarra L., Robles A.G., et al. Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation. Front Pharmacol. 2024; 15: 1384213. https://doi.org/10.3389/fphar.2024.1384213.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Miele C., Mennitti C., Gentile A., et al. Thrombosis and thrombotic risk in athletes. J Clin Med. 2024; 13 (16): 4881. https://doi.org/10.3390/jcm13164881.</mixed-citation><mixed-citation xml:lang="en">Miele C., Mennitti C., Gentile A., et al. Thrombosis and thrombotic risk in athletes. J Clin Med. 2024; 13 (16): 4881. https://doi.org/10.3390/jcm13164881.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Brennan F.H. Diagnosis, management of, and return to play guidance for venous thromboembolism in athletes. Curr Sports Med Rep. 2022; 21 (4): 129–36. https://doi.org/10.1249/JSR.0000000000000949.</mixed-citation><mixed-citation xml:lang="en">Brennan F.H. Diagnosis, management of, and return to play guidance for venous thromboembolism in athletes. Curr Sports Med Rep. 2022; 21 (4): 129–36. https://doi.org/10.1249/JSR.0000000000000949.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Abrashev H., Abrasheva D., Nikolov N., et al. A systematic review of endothelial dysfunction in chronic venous disease – inflammation, oxidative stress, and shear stress. Int J Mol Sci. 2025; 26 (8): 3660. https://doi.org/10.3390/ijms26083660.</mixed-citation><mixed-citation xml:lang="en">Abrashev H., Abrasheva D., Nikolov N., et al. A systematic review of endothelial dysfunction in chronic venous disease – inflammation, oxidative stress, and shear stress. Int J Mol Sci. 2025; 26 (8): 3660. https://doi.org/10.3390/ijms26083660.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Lu M., Qi X., Bi J., Li Y. Impact of the post-thrombotic syndrome on the arterial wall of the lower limbs. Clin Appl Thromb Hemost. 2022; 28: 10760296221117473. https://doi.org/10.1177/10760296221117473.</mixed-citation><mixed-citation xml:lang="en">Lu M., Qi X., Bi J., Li Y. Impact of the post-thrombotic syndrome on the arterial wall of the lower limbs. Clin Appl Thromb Hemost. 2022; 28: 10760296221117473. https://doi.org/10.1177/10760296221117473.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Creber A., Leo D.G., Buckley B.J.R., et al. Use of telemonitoring in patient self-management of chronic disease: a qualitative metasynthesis. BMC Cardiovasc Dis. 2023; 23 (1): 469. https://doi.org/10.1186/s12872-023-03486-3.</mixed-citation><mixed-citation xml:lang="en">Creber A., Leo D.G., Buckley B.J.R., et al. Use of telemonitoring in patient self-management of chronic disease: a qualitative metasynthesis. BMC Cardiovasc Dis. 2023; 23 (1): 469. https://doi.org/10.1186/s12872-023-03486-3.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Chan A.H.Y., Foot H., Pearce C.J., et al. Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: a systematic review and meta-analysis. PLoS One. 2022; 17 (3): e0265715. https://doi.org/10.1371/journal.pone.0265715.</mixed-citation><mixed-citation xml:lang="en">Chan A.H.Y., Foot H., Pearce C.J., et al. Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: a systematic review and meta-analysis. PLoS One. 2022; 17 (3): e0265715. https://doi.org/10.1371/journal.pone.0265715.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Middeldorp S., Nieuwlaat R., Baumann Kreuziger L., et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. 2023; 7 (22): 7101–38. https://doi.org/10.1182/bloodadvances.2023010177.</mixed-citation><mixed-citation xml:lang="en">Middeldorp S., Nieuwlaat R., Baumann Kreuziger L., et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. 2023; 7 (22): 7101–38. https://doi.org/10.1182/bloodadvances.2023010177.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Key N.S., Khorana A.A., Kuderer N.M., et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. J Clin Oncol. 2023; 41 (16): 3063–71. https://doi.org/10.1200/JCO.23.00294.</mixed-citation><mixed-citation xml:lang="en">Key N.S., Khorana A.A., Kuderer N.M., et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. J Clin Oncol. 2023; 41 (16): 3063–71. https://doi.org/10.1200/JCO.23.00294.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Farge D., Frere C., Connors J.M., et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022; 23 (7): e334–47. https://doi.org/10.1016/S1470-2045(22)00160-7.</mixed-citation><mixed-citation xml:lang="en">Farge D., Frere C., Connors J.M., et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022; 23 (7): e334–47. https://doi.org/10.1016/S1470-2045(22)00160-7.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Stevens S.M., Woller S.C., Kreuziger L.B., et al. Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012–2021. Chest. 2024; 166 (2): 388–404. https://doi.org/10.1016/j.chest.2024.03.003.</mixed-citation><mixed-citation xml:lang="en">Stevens S.M., Woller S.C., Kreuziger L.B., et al. Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012–2021. Chest. 2024; 166 (2): 388–404. https://doi.org/10.1016/j.chest.2024.03.003.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Pelosi A.D., Roth N., Yehoshua T., et al. Personalized rehabilitation approach for reaching movement using reinforcement learning. Sci Rep. 2024; 14 (1): 17675. https://doi.org/10.1038/s41598-024-64514-6.</mixed-citation><mixed-citation xml:lang="en">Pelosi A.D., Roth N., Yehoshua T., et al. Personalized rehabilitation approach for reaching movement using reinforcement learning. Sci Rep. 2024; 14 (1): 17675. https://doi.org/10.1038/s41598-024-64514-6.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Râdulescu R.M. Personalized rehabilitation programs: tailoring recovery through artificial intelligence. Appl Med Informatics. 2023; 45 (Suppl. S1): S11.</mixed-citation><mixed-citation xml:lang="en">Râdulescu R.M. Personalized rehabilitation programs: tailoring recovery through artificial intelligence. Appl Med Informatics. 2023; 45 (Suppl. S1): S11.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Aharon K.B., Gershfeld-Litvin A., Amir O., et al. Improving cardiac rehabilitation patient adherence via personalized interventions. PLoS One. 2022; 17 (8): e0273815. https://doi.org/10.1371/journal.pone.0273815.</mixed-citation><mixed-citation xml:lang="en">Aharon K.B., Gershfeld-Litvin A., Amir O., et al. Improving cardiac rehabilitation patient adherence via personalized interventions. PLoS One. 2022; 17 (8): e0273815. https://doi.org/10.1371/journal.pone.0273815.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
